India’s Covaxin vaccine has been approved by Saudi Arabia for travel. An announcement was made by the Indian Embassy in Saudi Arabia that fully vaccinated Indian citizens can enter the country restriction-free.
The official Twitter account India in Saudi Arabia, @IndianEmbRiyadh, Tweeted this:
“Embassy is pleased to inform that Indian nationals vaccinated with ‘Covaxin’ are now approved to enter the Kingdom. Vaccine certificates are to be uploaded at https://eservices.moh.gov.sa/CoronaVaccineRegistration for residents and at https://muqeem.sa/#/vaccine-registration/home for visitors.”
The Tweet also tagged the official Twitter account of Saudi Arabia’s Ministry of Health, as well as the official account of India’s Ministry of External Affairs’ Official Spokesperson Arindam Bagchi.
Bharat Biotech created Covaxin, which is slowly but surely gaining acknowledgment in several countries. Emergency use approval of the vaccine was issued by the World Health Organization (WHO) back in November 2021.
Prior to this, Indian vaccine Covishield was the only one that had WHO approval.
Saudi Arabia joins the United States, the United Kingdom, Australia and Switzerland in recognizing Covaxin as an acceptable vaccine for travel.
Other approved vaccines in Saudi Arabia so far include Johnson & Johnson, Moderna, Oxford-Astrazeneca, Pfizer, Sinopharm and Sinovac.
Photo: Times of India